Financial statements Biofaktor
Cash inflows of BIOFAKTOR
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 5 076 176,21 | 3 766 797,21 | 2 329 580,37 | 2 612 158,40 | 4 856 700,01 | 4 237 771,49 |
| Net cash flow from investing activities | -3 220 241,58 | -4 135 405,39 | -4 983 160,14 | -891 162,75 | -2 711 041,75 | -1 099 361,52 |
| Net cash flow from financial activities | -1 938 797,46 | 525 680,79 | 3 061 509,49 | -2 052 000,00 | -2 349 321,13 | -2 565 048,83 |
| Total net cash flow | -82 862,83 | 157 072,61 | 407 929,72 | -331 004,35 | -203 662,87 | 573 361,14 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.